{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:15:28Z","timestamp":1793423728503,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2135"],"award-info":[{"award-number":["JPMJSP2135"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jlr.2025.100874","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:48:31Z","timestamp":1754495311000},"page":"100874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chromatin remodeler BRD9 represses transcription of PPAR\u03b1 target genes, including CPT1A to suppress lipid metabolism"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1520-5561","authenticated-orcid":false,"given":"Itsuki","family":"Yokoseki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9884-2768","authenticated-orcid":false,"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9499-3204","authenticated-orcid":false,"given":"Kiamu","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-8828","authenticated-orcid":false,"given":"Shotaro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7696-5814","authenticated-orcid":false,"given":"Nao","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-2454","authenticated-orcid":false,"given":"Hiroshi","family":"Suemizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5988","authenticated-orcid":false,"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100874_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"Can Med. Assoc. J."},{"key":"10.1016\/j.jlr.2025.100874_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12944-020-1197-y","article-title":"The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study","volume":"19","author":"Liang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2025.100874_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2025.100874_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCULATIONAHA.114.013189","article-title":"Statin intolerance","volume":"131","author":"Fitchett","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100874_bib5","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2025.100874_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0960-0760(94)90089-2","article-title":"Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators","volume":"51","author":"Mukherjee","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100874_bib7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jlr.2025.100874_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100874_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jlr.2025.100874_bib10","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor \u03b1 in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2025.100874_bib11","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.272.52.33435","article-title":"p300 functions as a coactivator for the peroxisome proliferator-activated receptor \u03b1","volume":"52","author":"Dowell","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100874_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmet.2008.06.013","article-title":"Genome-wide coactivation analysis of PGC-1\u03b1 identifies BAF60a as a regulator of hepatic lipid metabolism","volume":"8","author":"Li","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100874_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrm1945","article-title":"Chromatin remodelling: the industrial revolution of DNA around histones","volume":"7","author":"Saha","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2025.100874_bib14","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","article-title":"A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation","volume":"20","author":"Michel","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jlr.2025.100874_bib15","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41467-018-07528-9","article-title":"A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells","volume":"9","author":"Gatchalian","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100874_bib16","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.06004","article-title":"The BRG1 transcriptional coregulator","volume":"6","author":"Trotter","year":"2008","journal-title":"Nucl. Recept Signal."},{"key":"10.1016\/j.jlr.2025.100874_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2018.04.013","article-title":"Vitamin D switches BAF complexes to protect \u03b2 cells","volume":"173","author":"Wei","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2025.100874_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ebiom.2019.03.021","article-title":"Arid1a regulates insulin sensitivity and lipid metabolism","volume":"42","author":"Qu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jlr.2025.100874_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/00498254.2018.1495346","article-title":"Expression and inducibility of cytochrome P450s in human hepatocytes isolated from chimeric mice with human livers","volume":"49","author":"Uehara","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jlr.2025.100874_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115733","article-title":"ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver","volume":"215","author":"Kurosawa","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100874_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2020.11.002","article-title":"Adenosine deaminases acting on RNA modulate the expression of the human pregnane X receptor","volume":"37","author":"Takemoto","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jlr.2025.100874_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gr.5533506","article-title":"FAIRE (formaldehyde-assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin","volume":"17","author":"Giresi","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.jlr.2025.100874_bib23","doi-asserted-by":"crossref","first-page":"E969","DOI":"10.1152\/ajpendo.00497.2007","article-title":"A moderate increase in carnitine palmitoyltransferase 1\u03b1 activity is sufficient to substantially reduce hepatic triglyceride levels","volume":"294","author":"Stefanovic-Racic","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2025.100874_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.jlr.2025.100874_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","article-title":"Peroxisome proliferator activated receptor \u03b1 (PPAR\u03b1) and PPAR gamma coactivator (PGC-1\u03b1) induce carnitine palmitoyltransferase 1A (CPT-1A) via independent gene elements","volume":"325","author":"Song","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jlr.2025.100874_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPAR\u03b1 between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLOS One"},{"key":"10.1016\/j.jlr.2025.100874_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jlr.2025.100874_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jmb.2005.09.097","article-title":"An intronic peroxisome proliferator-activated receptor-binding sequence mediates fatty acid induction of the human carnitine palmitoyltransferase 1A","volume":"354","author":"Napal","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100874_bib29","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"Thompson, the SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jlr.2025.100874_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13238-017-0442-2","article-title":"The SWI\/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.jlr.2025.100874_bib31","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41598-019-41713-0","article-title":"BRD7 deficiency leads to the development of obesity and hyperglycemia","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100874_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cmet.2014.04.006","article-title":"BRD7 regulates XBP1s\u2019 activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K","volume":"20","author":"Park","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2025.100874_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/mol.109.059063","article-title":"The human ADFP gene is a direct liver-X-receptor (LXR) target gene and differentially regulated by synthetic LXR ligands","volume":"77","author":"Kotokorpi","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jlr.2025.100874_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","article-title":"BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression","volume":"81","author":"Alpsoy","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.jlr.2025.100874_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnut.2022.831879","article-title":"Hepatic PPAR\u03b1 is destabilized by SIRT1 deacetylase in undernourished male mice","volume":"9","author":"Suh","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jlr.2025.100874_bib36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0969-2126(01)00634-7","article-title":"Structure of the PPAR\u03b1 and -\u03b3 ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family","volume":"9","author":"Cronet","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.jlr.2025.100874_bib37","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.jmedchem.5b01865","article-title":"Structure-based design of an in vivo active selective BRD9 inhibitor","volume":"59","author":"Martin","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100874_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jlr.2025.100874_bib39","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jlr.2025.100874_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/db21-0363","article-title":"Hepatic CPT1A facilitates liver-adipose cross talk via induction of FGF21 in mice","volume":"71","author":"Sun","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2025.100874_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116412","article-title":"BI-7273, a BRD9 inhibitor, reduces lipid accumulation by downregulating the AKT\/mTOR\/SREBP1 signaling pathway","volume":"226","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100874_bib42","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-05-2556","article-title":"Peroxisome proliferator-activated receptor \u03b1 activation decreases metastatic potential of melanoma cells in vitro via downregulation of Akt","volume":"12","author":"Grabacka","year":"2006","journal-title":"Clin. Can Res."},{"key":"10.1016\/j.jlr.2025.100874_bib43","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.jlr.2025.100874_bib44","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jmb.2013.05.010","article-title":"Molecular mechanism of peroxisome proliferator-activated receptor \u03b1 activation by WY14643: a new mode of ligand recognition and receptor stabilization","volume":"425","author":"Bernardes","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100874_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00125-005-0070-x","article-title":"Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects","volume":"49","author":"Holt","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jlr.2025.100874_bib46","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","article-title":"Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100874_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cell.2020.09.051","article-title":"A structure model of the endogenous human BAF complex informs disease mechanisms","volume":"183","author":"Mashtalir","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2025.100874_bib48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2025.100874_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-1336-3-3","article-title":"Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms","volume":"3","author":"Tachibana","year":"2005","journal-title":"Nucl. Recept"},{"key":"10.1016\/j.jlr.2025.100874_bib50","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jlr.2025.100874_bib51","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.1074\/jbc.M702819200","article-title":"Knock down of \u03b3-glutamylcysteine synthetase in rat cause acetaminophen-induced hepatotoxicity","volume":"282","author":"Akai","year":"2007","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:00:46Z","timestamp":1758787246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022227525001361"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100874","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromatin remodeler BRD9 represses transcription of PPAR\u03b1 target genes, including CPT1A to suppress lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100874"}}